Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT01027468
Eligibility Criteria:
Inclusion Criteria:
* any subtype of neovascular age-related macular degeneration
* age of 50 years or older
* initial treatment with intravitreal bevacizumab between August 2005 and June 2006
Exclusion Criteria:
* previous vitrectomy
* presence of cystoid macular edema without choroidal neovascularization
* Uncontrolled systemic disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT01027468
Study Brief:
Protocol Section:
NCT01027468